Gelonghui, April 12, 丨 Boan Biotech (06955.HK) announced that on April 12, 2024, the company entered into a loan financing agreement with China Jingu International Trust Co., Ltd. (the “Lender”). Based on this, the lender agreed to provide the Company with a term loan of RMB 300 million.
The board of directors believes that this financing will help advance the company's development strategy, enable the company to rapidly develop and market various products, and potentially accelerate the pace of successful commercialization. The financing is in line with the company's long-term goals and leverages the huge market potential of its product pipeline. The company is prepared to use this financing to effectively enhance its business operations, thereby creating value for shareholders and stakeholders.